Keyword: R&D

News

Trinseo Opens R&D Center in the Netherlands

29.09.2017 - US performance materials and plastics company Trinseo, formerly part of Dow Chemical, has opened a new research and development facility in Terneuzen, the Netherlands. Trinseo has...

Plant Construction & Process Technology

Ensuring Better Efficiency and Consistency

28.09.2017 - Does the consolidation in the pharmaceutical industry affect CROs/CMOs, e.g. does it create a necessity for outsourcing partners to consolidate, too? Mark Rogers: Between 1993 and...

Plant Construction & Process Technology

Pharma R&D Productivity Needs Improvement

28.09.2017 - Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Elliott Berger: With the ever-increasing share of...

Plant Construction & Process Technology

Confidentiality is a Potential Pitfall

28.09.2017 - Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. What do the outsourcing partners have to do in order to...

Plant Construction & Process Technology

Consolidation is here to Stay

28.09.2017 - Jane Griffiths: Consolidation in the pharma industry is here to stay: as market competition increases, M&As are one of the fastest ways for companies to obtain critical mass...

Plant Construction & Process Technology

Changes in Portfolios and Pipelines are Likely

28.09.2017 - Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Marcus Hannakam: We think consolidation will proceed...

Plant Construction & Process Technology

Setting High Standards

28.09.2017 - Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. How big of an issue is a merger or an acquisition for...

Plant Construction & Process Technology

A Partner to Relieve the Strain

28.09.2017 - Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will it even intensify? Denis Angioletti: Consolidation in the pharma...